Bridget Dolan QC represents three patients to be given pioneering treatment for Creutzfeldt-Jakob disease
29th January 2019
The Court of Protection yesterday authorised a third incapable person commencing a novel potential treatment for sCJD. Bridget Dolan QC has represented three patients through the Official Solicitor in this series of cases. That there is no known treatment for this devastating disease has been a significant factor in the court approving administration of PRN100 to incapable persons in the absence of any prior clinical trials in humans.
Back to index